Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Top 20 Pharma Ranks: As Some Move Up, Others Fall Down

Sanofi and Gilead moved down in the rankings of Scrip's top 100 pharmaceutical companies, based on 2017 pharma sales, while Johnson & Johnson, GSK and AbbVie moved up. Shire joined the top 20 just as it is about to be consumed by Takeda.

Commercial Business Strategies Market Intelligence

Major M&A Bookends Year Of Mainly Steady Growth For Leading Medtech Groups

Scrip's latest rankings of the top 100 revenue earners in the medical technology industry, published in Outlook 2019, show the groups leading the global market tightening their grip further in 2017. This was partly a function of providers choosing to partner more and more with fewer suppliers who can offer a wider provision of services. But it was steady as she goes for most of the multinational medtechs, with some major exceptions, and there will be more M&A reflected in next year's rankings, based on 2018 revenues.

Outlook 2019 Market Intelligence Commercial

Infographic: Scrip 100 Numbers Crunched

The Scrip 100 universe gathers FY 2017 financial performance data and compares the activities of the Top 100 biopharma businesses, ranked by pharma sales.


Advertisement

The full Scrip 100 data set for 2019 is now available and includes data on R&D spending, total revenues, employee numbers and sales for 100 biopharmaceutical companies.

If you are a Scrip subscriber, click here to download the data in Excel format.

UsernamePublicRestriction

Register

Advertisement